Background: The pathogenesis of androgenic alopecia is not fully understood. A microbial-driven inflammatory reaction abutting on the hair follicles might participate in the hair status anomaly. Objective: The aim of our study was to determine if ketoconazole (KCZ) which is active against the scalp microflora and shows some intrinsic anti-inflammatory activity might improve alopecia. Method: The effect of 2% KCZ shampoo was compared to that of an unmedicated shampoo used in combination with or without 2% minoxidil therapy. Results: Hair density and size and proportion of anagen follicles were improved almost similarly by both KCZ and minoxidil regimens. The sebum casual level appeared to be decreased by KCZ. Conclusion: Comparative data suggest that there may be a significant action of KCZ upon the course of androgenic alopecia and that Malassezia spp. may play a role in the inflammatory reaction. The clinical significance of the results awaits further controlled study in a larger group of subjects.

Keywords:
Androgenic alopecia, Ketoconazole, Minoxidil, Malassezia spp.
1.
Jaworsky C, Kligman AM, Murphy GF: Characterization of inflammatory infiltrates in male pattern alopecia: Implications for pathogenesis. Br J Dermatol 1992;127:239–246.
2.
Piérard GE, Piérard-Franchimont C, Nikkels-Tassoudji N, Nikkels AF, Saint-Léger D: Improvement in the inflammatory aspect of androgenetic alopecia: A pilot study with an antimicrobial lotion. J Dermatol Treat 1996;7: 153–157.
3.
Hoffmann R, Happle R: Does interleukin-1 induce hair loss? Dermatology 1995;191: 273–275.
4.
Ford GP, Farr PM, Ive FA, Shuster S: The response of seborrhoeic dermatitis to ketoconazole. Br J Dermatol 1984;111:603–607.
5.
Skinner RB, Noah PW, Taylor RM, Zanolli MD, West S, Guin JD, Rosenberg EW: Double-blind treatment of seborrheic dermatitis with 2% ketoconazole cream. J Am Acad Dermatol 1985;12:852–856.
6.
Piérard GE, Piérard-Franchimont C, Van Cutsem J, Rurangirwa A, Hoppenbrouwers ML, Schrooten P: Ketoconozole 2% emulsion in the treatment of seborrheic dermatitis. Int J Dermatol 1991;30:806–809.
7.
Beetens JR, Loots W, Somers Y, Coene MC, De Clerck F: Ketoconazole inhibits the biosynthesis of leukotrienes in vitro and in vivo. Biochem Pharmacol 1986;35:883–891.
8.
Van Cutsem J, Van Gerven F, Cauwenbergh G, Odds F, Janssen PAJ: The antiinflammatory effects of ketoconazole. J Am Acad Dermatol 1991;25:257–261.
9.
Yoshimura T, Kudoh K, Aiba S, Tagami H: Anti-inflammatory effects of topical ketoconazole for the inflammation induced on the skin of hairless guinea-pigs by repeated applications of heat-killed spores of Malassezia furfur: A comparative study with hydrocortisone 17-butyrate. J Dermatol Treat 1995;6:113–116.
10.
Saint-Léger D, Kligman AM, Stoudemayer TJ: The role of the resident microflora in the pathogenesis of dandruff. J Soc Cosmet Chem 1989; 40:109–117.
11.
Piérard-Franchimont C, Arrese JE, Piérard GE: Immunohistochemical aspects of the link between Malassezia ovalis and seborrheic dermatitis. J Eur Acad Dermatol Venereol 1995;4: 14–19.
12.
Hamilton JB; Patterned loss of hair in man: Types and incidence. Ann NY Acad Sci 1951; 53:708–728.
13.
Norwood OT: Male pattern baldness: Classification and incidence. South Med J 1975;68: 1359–1365.
14.
Piérard-Franchimont C, Piérard GE: Approche physiopathologique de la séborrhée du cuir chevelu. Ann Dermatol Vénéréol 1988;115: 451–453.
15.
Rushton DH, Ramsay ID, Norris MJ, Gilkes JJH: Natural progression of male pattern baldness in young men. Clin Exp Dermatol 1991; 16:188–192.
16.
Brown M, Evans TW, Poyner T, Tooley PJH: The role of ketoconazole 2% shampoo in the treatment and prophylactic management of dandruff. J Dermatol Treat 1990;1:177–179.
17.
Dobrev H, Zissova L: Effect of ketoconazole 2% shampoo on scalp sebum level in patients with seborrhoeic dermatitis. Acta Derm Venereol 1997;77:132–134.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.